DK1299095T3 - Klart vandigt anæstetisk præparat - Google Patents

Klart vandigt anæstetisk præparat

Info

Publication number
DK1299095T3
DK1299095T3 DK00991825T DK00991825T DK1299095T3 DK 1299095 T3 DK1299095 T3 DK 1299095T3 DK 00991825 T DK00991825 T DK 00991825T DK 00991825 T DK00991825 T DK 00991825T DK 1299095 T3 DK1299095 T3 DK 1299095T3
Authority
DK
Denmark
Prior art keywords
clear aqueous
anesthetic preparation
aqueous anesthetic
preparation
clear
Prior art date
Application number
DK00991825T
Other languages
Danish (da)
English (en)
Inventor
Shilpa Kocharekar
Srikanth Pai
Sangeeta Rivankar
Original Assignee
Bharat Serums & Vaccines Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bharat Serums & Vaccines Ltd filed Critical Bharat Serums & Vaccines Ltd
Application granted granted Critical
Publication of DK1299095T3 publication Critical patent/DK1299095T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40Cyclodextrins; Derivatives thereof
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Medical Informatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK00991825T 2000-06-21 2000-12-14 Klart vandigt anæstetisk præparat DK1299095T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN573MU2000 IN187686B (fr) 2000-06-21 2000-06-21

Publications (1)

Publication Number Publication Date
DK1299095T3 true DK1299095T3 (da) 2004-10-11

Family

ID=11097257

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00991825T DK1299095T3 (da) 2000-06-21 2000-12-14 Klart vandigt anæstetisk præparat

Country Status (26)

Country Link
US (1) US7138387B2 (fr)
EP (1) EP1299095B1 (fr)
JP (1) JP4907833B2 (fr)
KR (1) KR100810066B1 (fr)
CN (1) CN1254237C (fr)
AP (1) AP2002002674A0 (fr)
AT (1) ATE267592T1 (fr)
AU (2) AU2001235972B2 (fr)
BG (1) BG107463A (fr)
BR (1) BR0017268A (fr)
CA (1) CA2414064C (fr)
DE (1) DE60011149T2 (fr)
DK (1) DK1299095T3 (fr)
EA (1) EA005589B1 (fr)
ES (1) ES2222271T3 (fr)
HU (1) HUP0301646A3 (fr)
IL (1) IL153387A0 (fr)
IN (1) IN187686B (fr)
MX (1) MXPA02012611A (fr)
NO (1) NO20025999L (fr)
NZ (1) NZ523643A (fr)
PL (1) PL359624A1 (fr)
PT (1) PT1299095E (fr)
WO (1) WO2001097796A1 (fr)
YU (1) YU2703A (fr)
ZA (1) ZA200300336B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN188917B (fr) * 2000-12-07 2002-11-23 Bharat Surums & Vaccines Ltd
US7034013B2 (en) 2001-03-20 2006-04-25 Cydex, Inc. Formulations containing propofol and a sulfoalkyl ether cyclodextrin
US20050042280A1 (en) * 2001-12-28 2005-02-24 Rogers Tracey L. Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol
EP1469886B8 (fr) * 2002-02-01 2008-01-09 Shimoda Biotech (PTY) LTD Composition pharmaceutique lyophilisée de propofole
US7550155B2 (en) 2002-07-29 2009-06-23 Transform Pharmaceuticals Inc. Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses
CA2494297C (fr) 2002-07-29 2011-10-18 Transform Pharmaceuticals, Inc. Compositions pharmaceutiques de 2,6-diisopropylphenol aqueux
KR20200083657A (ko) * 2002-12-09 2020-07-08 아브락시스 바이오사이언스, 엘엘씨 약리학적 물질의 조성물 및 그 전달방법
JPWO2005067905A1 (ja) * 2004-01-14 2007-12-27 株式会社大塚製薬工場 プロポフォール含有脂肪乳剤
EA200700440A1 (ru) * 2004-09-13 2008-02-28 Бхарат Сирумс Энд Вэксинс Лтд. Композиции стабильных эмульсий для внутривенного введения, имеющие защитную эффективность
BRPI0614628A2 (pt) * 2005-08-12 2011-04-12 Bharat Serums & Vaccines Ltd composição anestésica aquosa adequada para a administração parenteral; processo de produção de uma composição anestésica aquosa adequada para a administração parenteral; composição anestésica aquosa; e processo de produção de uma composição anestésica aquosa
WO2007128866A2 (fr) * 2006-05-09 2007-11-15 Novobion Oy Nouvelles compositions chimiques
TWI450043B (zh) * 2008-03-11 2014-08-21 3M Innovative Properties Co 具備保護層之光工具
WO2010148288A2 (fr) * 2009-06-19 2010-12-23 Lyotropic Therapeutics, Inc. Formulations pharmaceutiques avec de faibles taux aqueux de médicament non lié libre
US9096712B2 (en) 2009-07-21 2015-08-04 3M Innovative Properties Company Curable compositions, method of coating a phototool, and coated phototool
KR101781659B1 (ko) 2009-09-16 2017-09-25 쓰리엠 이노베이티브 프로퍼티즈 컴파니 플루오르화된 코팅 및 그로 제조된 포토툴
KR101768237B1 (ko) 2009-09-16 2017-08-14 쓰리엠 이노베이티브 프로퍼티즈 컴파니 플루오르화된 코팅 및 그로 제조된 포토툴
US8268067B2 (en) * 2009-10-06 2012-09-18 3M Innovative Properties Company Perfluoropolyether coating composition for hard surfaces
EP2345427A1 (fr) * 2010-01-14 2011-07-20 SapioTec GmbH Complexe de flurane
DK2484350T3 (en) * 2011-02-04 2016-08-01 Norbert Univ -Prof Dr Med Roewer A pharmaceutical composition containing a complex of a cyclodextrin with a propofolsalt
AU2013273764B2 (en) * 2011-11-29 2016-05-05 Zoetis Services Llc Pharmaceutical compositions
KR101922752B1 (ko) * 2011-11-29 2018-11-27 주록스 피티와이 리미티드 사이클로덱스트린 및 소수성 약물을 포함하는 주사용 약제학적 조성물을 보존하는 방법
CN103263404B (zh) * 2012-04-28 2017-12-01 中国人民解放军军事医学科学院放射与辐射医学研究所 一种复合麻醉药物
IL304912A (en) 2012-08-21 2023-10-01 Sage Therapeutics Inc Treatment methods for epilepsy and status epilepticus
US10646439B2 (en) * 2016-01-29 2020-05-12 Cuda Anesthetics, Llc Aqueous pharmaceutical formulation comprising propofol
FR3117337B1 (fr) 2020-12-10 2023-04-28 Centre Hospitalier Univ De Lille Composition pharmaceutique contenant du propofol, une cyclodextrine ou un dérivé de cyclodextrine et un sel pharmaceuticalement acceptable

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA962214B (en) * 1995-04-10 1996-10-07 Farmarc Nederland Bv Pharmaceutical composition

Also Published As

Publication number Publication date
NZ523643A (en) 2004-05-28
NO20025999D0 (no) 2002-12-13
ATE267592T1 (de) 2004-06-15
HUP0301646A2 (hu) 2003-09-29
YU2703A (sh) 2006-03-03
AU3597201A (en) 2002-01-02
AU2001235972B2 (en) 2005-07-21
CA2414064A1 (fr) 2001-12-27
AP2002002674A0 (en) 2002-12-31
JP2003535893A (ja) 2003-12-02
HUP0301646A3 (en) 2005-06-28
BR0017268A (pt) 2003-05-27
PL359624A1 (en) 2004-08-23
ZA200300336B (en) 2004-04-08
WO2001097796A1 (fr) 2001-12-27
CA2414064C (fr) 2013-01-08
KR20030023875A (ko) 2003-03-20
IL153387A0 (en) 2003-07-06
BG107463A (en) 2003-11-28
MXPA02012611A (es) 2004-07-30
US7138387B2 (en) 2006-11-21
KR100810066B1 (ko) 2008-03-05
JP4907833B2 (ja) 2012-04-04
PT1299095E (pt) 2004-10-29
CN1454085A (zh) 2003-11-05
EA005589B1 (ru) 2005-04-28
CN1254237C (zh) 2006-05-03
DE60011149D1 (de) 2004-07-01
EA200300047A1 (ru) 2003-06-26
NO20025999L (no) 2002-12-13
EP1299095B1 (fr) 2004-05-26
IN187686B (fr) 2002-06-08
EP1299095A1 (fr) 2003-04-09
DE60011149T2 (de) 2005-07-07
US20040014718A1 (en) 2004-01-22
ES2222271T3 (es) 2005-02-01

Similar Documents

Publication Publication Date Title
DK1299095T3 (da) Klart vandigt anæstetisk præparat
DK1857105T3 (da) Kathartisk præparat
NO20031483L (no) Vaksine
NL1017075A1 (nl) Preparaat.
DE50104135D1 (de) Wässrige zusammensetzungen
NO20024172D0 (no) Vaksine
DE60124662T8 (de) Karosseriestruktur
IS6686A (is) Hýdrógel-drifið lyfjaskömmtunarform
DZ3409A1 (fr) Association therapeuthique
DK1199054T3 (da) Væskefrakturhånddel
NO20026175L (no) Vaksinesammensetning
DE60133295D1 (de) Sulphoniumsalz-verbindung
NO20023367L (no) Glyburide-preparat
FI20002644A (fi) Liitäntäalusta
EE200200420A (et) Linesoliid - kristallivorm II
DE60116202D1 (de) Perkutan absorbierende Zubereitung
DE60103683D1 (de) Wässrige Pestizidzusammensetzung
DE60032946D1 (de) Katheter
DE60234592D1 (de) Wässrige zusammensetzung
DK1389116T3 (da) Kathartisk præparat
BR0113783B1 (pt) Composição aquosa
NO20032957D0 (no) Farmasöytisk emulsjonspreparat
FR2817889B1 (fr) Coffrage
DE60107973D1 (de) Gewebehandlungszubereitung
DK1267974T3 (da) Inhalationsapparat